Total Payments
$223.30
2024 Payments
$19.00
Companies
8
Transactions
15
Medicare Patients
2,237
Medicare Billing
$245,172
Payment Breakdown by Category
Food & Beverage$223.30 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $223.30 | 15 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $75.40 | 5 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $38.70 | 3 | $0 (2022) |
| ABBVIE INC. | $32.38 | 2 | $0 (2022) |
| Merck Sharp & Dohme LLC | $19.00 | 1 | $0 (2024) |
| Vifor Pharma, Inc. | $17.78 | 1 | $0 (2022) |
| GlaxoSmithKline, LLC. | $16.68 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $12.28 | 1 | $0 (2019) |
| Allergan Inc. | $11.08 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $19.00 | 1 | Merck Sharp & Dohme LLC ($19.00) |
| 2023 | $34.98 | 2 | Janssen Pharmaceuticals, Inc ($34.98) |
| 2022 | $60.40 | 4 | E.R. Squibb & Sons, L.L.C. ($27.15) |
| 2021 | $40.61 | 3 | AbbVie Inc. ($16.91) |
| 2020 | $13.87 | 1 | Janssen Pharmaceuticals, Inc ($13.87) |
| 2019 | $26.68 | 2 | Janssen Pharmaceuticals, Inc ($14.40) |
| 2018 | $11.08 | 1 | Allergan Inc. ($11.08) |
| 2017 | $16.68 | 1 | GlaxoSmithKline, LLC. ($16.68) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/22/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/10/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/29/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/05/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.80 | General |
| Category: Cardiovascular | ||||||
| 05/04/2022 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Hyperkalemia | ||||||
| 03/30/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/26/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.35 | General |
| Category: Cardiovascular | ||||||
| 03/10/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.55 | General |
| Category: Cardiovascular | ||||||
| 02/18/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/03/2021 | AbbVie Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/16/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/18/2019 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $12.28 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/18/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/13/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $11.08 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/17/2017 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 415 | 542 | $724,636 | $44,881 |
| 2022 | 9 | 509 | 734 | $888,106 | $54,484 |
| 2021 | 8 | 597 | 896 | $1.1M | $66,602 |
| 2020 | 10 | 716 | 1,138 | $853,313 | $79,206 |
Total Patients
2,237
Total Services
3,310
Medicare Billing
$245,172
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 141 | 146 | $346,166 | $18,427 | 5.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 121 | 211 | $181,249 | $12,315 | 6.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 76 | 107 | $130,219 | $9,481 | 7.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 77 | 78 | $67,002 | $4,658 | 7.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 139 | 232 | $282,344 | $17,770 | 6.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 135 | 261 | $224,199 | $13,579 | 6.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 67 | 69 | $163,599 | $10,042 | 6.1% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 37 | 38 | $82,460 | $5,132 | 6.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 66 | 67 | $57,553 | $3,603 | 6.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 25 | 25 | $35,525 | $1,880 | 5.3% |
| 99226 | Follow-up observation care per day, typically 35 minutes | Facility | 2022 | 12 | 12 | $14,424 | $900.49 | 6.2% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 15 | 16 | $16,256 | $840.82 | 5.2% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 13 | 14 | $11,746 | $736.77 | 6.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 199 | 443 | $380,537 | $24,011 | 6.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 100 | 100 | $237,100 | $14,646 | 6.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 85 | 129 | $156,993 | $10,054 | 6.4% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 57 | 59 | $128,030 | $8,130 | 6.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 67 | 67 | $57,553 | $3,636 | 6.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 36 | 36 | $51,156 | $2,801 | 5.5% |
| 99225 | Subsequent observation care, typically 25 minutes per day | Facility | 2021 | 27 | 36 | $30,204 | $1,948 | 6.4% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 26 | 26 | $26,416 | $1,375 | 5.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 302 | 703 | $339,818 | $38,505 | 11.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 68 | 69 | $159,697 | $11,283 | 7.1% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 49 | 51 | $110,670 | $7,821 | 7.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 90 | 92 | $36,843 | $5,029 | 13.7% |
About Dr. Mohammad Rizwan, M.D
Dr. Mohammad Rizwan, M.D is a Internal Medicine healthcare provider based in Indianola, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124045679.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohammad Rizwan, M.D has received a total of $223.30 in payments from pharmaceutical and medical device companies, with $19.00 received in 2024. These payments were reported across 15 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($223.30).
As a Medicare-enrolled provider, Rizwan has provided services to 2,237 Medicare beneficiaries, totaling 3,310 services with total Medicare billing of $245,172. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Emergency Medicine
- Location Indianola, MS
- Active Since 07/17/2006
- Last Updated 03/21/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1124045679
Products in Payments
- XARELTO (Drug) $75.40
- ELIQUIS (Drug) $38.70
- AVYCAZ (Drug) $27.99
- DIFICID (Drug) $19.00
- Veltassa (Drug) $17.78
- NUCALA (Biological) $16.68
- DALVANCE (Drug) $15.47
- BRILINTA (Drug) $12.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.